Shares of AbbVie, Eli Lilly and Johnson & Johnson were on track to hit all-time highs Friday, in the latest signal that investor appetite for the biopharmaceutical sector is back.
Healthcare stocks have become a haven for investors ditching tech
Related Posts
Popular News
-
Fed interest rate decision June 2026: Fed holds rates steady
-
The 6% solution is gone: How overcrowded AI-powered trading has erased investors’ advantage
-
How to Block Apple’s Own Ads on Your iPhone, iPad, and Mac
-
This Five-Camera Blink Camera Bundle Is 65% Off Right Now, Its Lowest Price Ever
-
Where to get high yield on stablecoins in 2025: Top 5 projects
Latest News
The Best Books, Movies, Video Games, and Podcasts to Check Out After Watching ‘The Office’
We may earn a commission from links on this page. Anyone who has ever worked in an office (or imagined...
SOL Bounced To $72 As Tokenized Stock Trading Surges But Will It Hold?
Key takeaways:SOL’s rebound to $72 shows bullish futures and airdrop hopes, but falling TVL and low DEX volumes point to...
US court rejects EPA bid to ease regulations for coal-fired power plants
US court rejects EPA bid to ease regulations for coal-fired power plants
Can XRP Hold $1, or Is $0.70 Next?
XRP has fallen to a 20-month low near $1.05, down more than 70% from its 2025 high, in a year-long...
Welcome to Global Finances Daily, your go-to source for all things finance. Our mission is to provide our readers with valuable information and insights to help them achieve their financial goals and secure their financial future.